Results showed that 74% of Restylane Defyne-treated patients achieved significantly improved chin projection for up to 1 year. The Food and Drug Administration (FDA) has approved Restylane ® Defyne ...

FORT WORTH, Texas, Feb. 2, 2021 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane ® Defyne for the augmentation and correction of mild to ...

Hyaluronic acid 20mg/mL, lidocaine 3mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...

After her extensive training to receive a Medical Aesthetic Training Injectable and Dermal Fillers certificate, Leah Walker has been offering cosmetic injections for more than 10 years and shares her ...

The FDA has approved Restylane Lyft with lidocaine for augmentation of the chin region for adults aged 21 years and older ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Restylane Defyne for mild to moderate chin retrusion augmentation in adults older than 21 ...

Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, ...